Shawn David Roman - 15 Jun 2026 Form 4 Insider Report for Apyx Medical Corp (APYX)

Reporting relationship: Chief Operating Officer
Issuer ticker: APYX
Reported as of: 15 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Jun 2026, 17:15:02 UTC
Prior SEC filing: 15 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Shawn Roman

Key filing fact

Shawn David Roman filed Form 4 for Apyx Medical Corp (APYX) on 17 Jun 2026.

Key facts

This page summarizes Shawn David Roman's Form 4 filing for Apyx Medical Corp (APYX).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 17 Jun 2026, 17:15.

Change

Previous filing in this sequence was filed on 15 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002048672 Primary reporting owner

Roman Shawn David

Relationship: Chief Operating Officer
Address: C/O APYX MEDICAL CORPORATION, 5115 ULMERTON ROAD, CLEARWATER
Signature: /s/ Shawn Roman
Signature date: 17 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

APYX transaction

Common Stock

Options Exercise

Transaction value
Shares: +15,000
Change %
Price: $3.23^*
Shares after: 15,000
Date: 15 Jun 2026
Ownership: By The Roman Family Revocable Trust
Footnotes: F1

APYX transaction

Common Stock

Tax liability

Transaction value
Shares: -10,533
Change %: -39%
Price: $4.60^*
Shares after: 16,467
Date: 15 Jun 2026
Ownership: By The Roman Family Revocable Trust
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

APYX transaction Derivative

Stock option (right to buy)

Options Exercise

Transaction value
Shares: -15,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 15 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,000
Exercise price: $3.23
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Held by The Roman Family Revocable Trust of which Reporting Person is both a trustee and beneficiary.

Footnote F2

On June 15, 2026, the Reporting Person effected a net exercise of 15,000 stock options with an exercise price of $3.23 per share. Pursuant to the terms of the exercise, 10,533 shares otherwise issuable upon exercise were withheld by the issuer at a value of $4.60 per share to satisfy the aggregate exercise price, resulting in the issuance of 4,467 net shares to the Reporting Person.